Open AccessEffect of Isoniazid Intake on Ethionamide Pharmacokinetics and Target Attainment in Multidrug-Resistant Tuberculosis Patients
Author(s) -
Maxwell Chirehwa,
Richard Court,
Mariana de Kock,
Lubbe Wiesner,
Nihal de Vries,
Joseph W. Harding,
Tawanda Gumbo,
Gary Maartens,
Robin M. Warren,
Paolo Denti,
Helen McIlleron
Publication year - 2021
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.00278-21
Subject(s) - ethionamide , pharmacokinetics , isoniazid , liter , pharmacology , bioequivalence , tuberculosis , medicine , antibacterial agent , rifampicin , mycobacterium tuberculosis , antibiotics , microbiology and biotechnology , biology , ethambutol , pathology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom